UroGen Pharma Ltd

UroGen Pharma Ltd Stock

—P/E
€1.42BMarket capitalisation
-US$1.31Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

UroGen Pharma Ltd is registered in the following country: Israel (Exchange: USNASD).

Key metrics

Key metrics and master data for the UroGen Pharma Ltd stock.

Market capitalisation
€1.42B
P/E
—
P/B
-11.97
P/S
6.34
P/CF
-11.61
Issued shares 49M Units

Return

Here you can see the performance of the UroGen Pharma Ltd stock.

PeriodPerfor­mance
1 Week+19.31 %
1 Month-7.29 %
3 Months-35.06 %
6 Months+16.47 %
1 Year+40.71 %
YTD+44.35 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the UroGen Pharma Ltd share.

DateRatio
No data available.

Which ETF contains the UroGen Pharma Ltd stock?

The UroGen Pharma Ltd stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, UroGen Pharma Ltd has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the UroGen Pharma Ltd stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.